Published on 9 February 2022
Description:
Charting patient pathways with precision for better healthcare, Fairer and faster access to medicines in the NHS, Greater price transparency
Categories:
Pharmaceutical Market EuropePreview:
35 articles from this collection:
PME December 2021
2 - T40
3 - Comment
4 - PMLIVE T40
5 - Contents
6-7 - News
6-7 - PME - Pharma Market Europe Pharmaceutical News
8-9 - News
10-11 - Coronavirus news
12 - IT’S NOT ABOUT THE TECHNOLOGY
12 - Pharma Market Europe Darwin’s medicine
13 - TOUGH CHOICES
The technology responses to this pandemic have fallen far short of expectations
14 - WHEN SHALL WE MEET AGAIN?
15 - IDENTIFYING THE RIGHT TECHNICAL AND SOFTER SKILLS NEEDED
16-17 - Striving for greater price transparency
18-19 - Fairer and faster access to medicines in the NHS
20-21 - Key clinical trial considerations for the new normal and the future
18-19 - Empowering patients empowers results
22 - HAVAS LYNX GROUP
23 - ‘Impact That Matters’
24-25 - Artificial intelligence: a smart bet for the pharma industry
26 - Decentralised clinical trials: mapping patient pathways with a focus on patient-centricity
27 - Improving outcomes in oncology – patient-centricity and mental health
28 - Research News
29 - FEBRUARY Highlights
30-32 - Patient Pathway
33 - Mapping patient pathways – with a focus on patient-centricity
34 - Mapping patient pathways – with a focus on patient-centricity
35 - Should we stop talking about people as patients and start thinking of them as partners?
36-37 - REMOTE PATIENT MONITORING
38 - Mapping patient pathways with a focus on patient-centricity: the role of medical education
39 - Mapping patient pathways with a focus on patient-centricity: the role of medical education
40-41 - AI AND CLINICAL CARE
42-44 - Appointments
45 - Healthcare Comms News
46 - Q&A with Fiona McMillan
47 - Recruitment
43 - Pharma Market Europe (PME) Recruitment
48 - EBR
Pharmaceutical Market Europe (PME)
Pharmaceutical industry news, articles, jobs, reports, advice and services